Brain-targeted intranasal delivery of dopamine with borneol and lactoferrin co-modified nanoparticles for treating Parkinson's disease

• Auteurs principaux: Shengnan Tang (Auteur), Aiping Wang (Auteur), Xiuju Yan (Auteur), Liuxiang Chu (Auteur), Xiucheng Yang (Auteur), Yina Song (Auteur), Kaoxiang Sun (Auteur), Xin Yu (Auteur), Rongxia Liu (Auteur), Zimei Wu (Auteur), Peng Xue (Auteur)
• Format: Livre
• Publié: Taylor & Francis Group, 2019-01-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Efficient delivery of brain-targeted drugs is highly important for successful therapy in Parkinson's disease (PD). This study was designed to formulate borneol and lactoferrin co-modified nanoparticles (Lf-BNPs) encapsulated dopamine as a novel drug delivery system to achieve maximum therapeuti...